

Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing. Guofang Capital and InnoVision Capital led the round.
Source: Press Release
Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing.
Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing. Guofang Capital and InnoVision Capital led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination